{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-025524","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.635712+00:00","generated_at":"2026-05-26T22:11:55.683647+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Agios board member David Schenkein resigns effective Feb 28, 2025; stays as strategic advisor","bullets":["Dr. Schenkein notified company of resignation from board on Feb 10, 2025, effective Feb 28, 2025.","He will also cease serving on the Science and Technology Committee of the board.","He will continue as a strategic advisor to leadership, focusing on advancing clinical development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-025524","json":"https://secwatch.observer/filing/0001193125-25-025524.json","markdown":"https://secwatch.observer/filing/0001193125-25-025524.md","text":"https://secwatch.observer/filing/0001193125-25-025524.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312525025524/0001193125-25-025524-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312525025524/d927492d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:11:55.683647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10d5da77de","claim":"David P. Schenkein, M.D. resigned as Director at AGIOS PHARMACEUTICALS, INC..","evidence_excerpt":"On February 10, 2025, David P. Schenkein, M.D., notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective February 28, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439222/000119312525025524/0001193125-25-025524-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}